ArticleBMC pharmacology & toxicology2026
Neuropsychiatric adverse event reporting with GLP-1-based therapies: a post-marketing pharmacovigilance analysis using the WHO global individual case safety report database (VigiBase).
Jizhou Liang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.